Clinical Handbook of Psychotropic Drugs 24th Edition

Clinical Handbook of Psychotropic Drugs 24th Edition
by Ric M. Procyshyn (Author), Kalyna Z. Bezchlibnyk-Butler (Author), J. Joel Jeffries (Author)
Publisher ‏ : ‎ Hogrefe Publishing; 24th edition (July 15, 2021)
Language ‏ : ‎ English
FORMAT: ORIGINAL PDF/ PRINT REPLICA
ISBN-10 ‏ : ‎ 0889375933
ISBN-13 ‏ : ‎ 978-0889375932

$12.99

In stock

SKU: clinical-handbook-of-psychotropic-drugs-24th-edition Category: Mental - Behavioral Sciences Tag: Psychiatry

Description

Clinical Handbook of Psychotropic Drugs 24th Edition

by Ric M. Procyshyn (Author), Kalyna Z. Bezchlibnyk-Butler (Author), J. Joel Jeffries (Author)

Publisher ‏ : ‎ Hogrefe Publishing; 24th edition (July 15, 2021)
Language ‏ : ‎ English
FORMAT: ORIGINAL PDF/ PRINT REPLICA
ISBN-10 ‏ : ‎ 0889375933
ISBN-13 ‏ : ‎ 978-0889375932

The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.

Independent, unbiased, up-to-date
Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug
Potential interactions and side effects summarized in comparison charts
With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
Clearly written patient information sheets available for download as printable PDF files

This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.

New in this edition:

Neuroscience-based nomenclature – added to product availability tables
Antidepressants chapter includes new section on GABAA receptor positive modulator (brexanolone IV injection; trade name Zulresso); also updates to SSRI use in pregnancy and antidepressant augmentation strategies
Antipsychotics updates include revised dosing, especially adjustments in hepatic and renal impairment
Mood stabilisers chapter sections on Lithium and Anticonvulsants have been extensively revised
New formulations and trade names include: Adhansia XR (methylphenidate extended-release capsules), Caplyta (lumateperone), Dayvigo (lemborexant), Perseris (risperidone extended-release subcutaneous injection), Probuphine (buprenorphine subdermal implant), Propecia (finasteride tablets), Trelstar (triptorelin slow-release injection), Qelbree (viloxazine extended-release capsules)

Previous praise for the Clinical Handbook This is the new edition [23rd] of a very important book that provides valuable information which otherwise would be scattered among different publications. With the increasing rate of prescription of psychotropic drugs, this volume should be on the desk of every physician. The information is crucial for understanding side effects, vulnerabilities, and interactions of psychotropic drug treatment --Psychotherapy and Psychosomatics

Praise for a previous edition: As a psychiatrist who routinely prescribes medications, I find this handbook invaluable. It is the most comprehensive book on this topic that I have come across. --Corey Goldstein, MD, Rush University Medical Center

Praise for a previous edition: A powerhouse of practical information ... Unrivalled in scope ... This outstanding and unique handbook is as rich in useful content as many full textbooks.” --Barbara Jovaisas, PharmD, in Canadian Pharmacists Journal

This book is a valuable quick reference tool - a clinical resource guide for practitioners who utilize psychotropic drugs in any care setting. For pharmacists, this comprehensive resource allows for quick access to information needed to guide clinical decisions and dispense medications safely. A unique aspect is the incorporation of evidence-based best practices and up-to-date literature into the prescribing information, which elevates it from a basic drug database. In addition, the use of charts and tables enables users to access information quickly, making the book a useful tool for clinical decision making. Reviewed by Marissa Cavaretta, PharmD, Temple University School of Pharmacy, Philadelphia, PA, in Doody’s Reviews (2022).

About the Author

Ric M. Procyshyn; BScPharm, MSc, PharmD, PhD; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; British Columbia Mental Health & Addictions Research Institute, Vancouver, BC, Canada.<br><br> Kalyna Z. Bezchlibnyk-Butler; BScPharm, FCSHP; Toronto, ON, Canada.<br><br> J. Joel Jeffries; MB, FRCPC, DFCPA; Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, ON, Canada

About PDF Formats (General)